Research Dissemination Speakers Presentation Title Presentation Summary Learning Objectives Atopic Dermatitis: new and old treatment updates

Similar documents
OMED rd Osteopathic Medical Conference & Exposition October 5 9, 2018 ~ San Diego, CA

ADVANCED NEUROIMAGING IN CONCUSSION: A TRANSLATIONAL COLLABORATION OPPORTUNITY

Treatment Issues: The Opiate Crisis Among Us

OPIOIDS IN AMERICA. A complex crisis. A comprehensive response.

Opioid Abuse. in Rural Minnesota. County Farm Bureau Resource Guide

Coalition Strategies Across The Continuum of Care

Strategic Plan

TREATING OPIOID ADDICTION IN HOMELESS POPULATIONS

Addressing Alaska s Opioid Epidemic From Understanding to Action

Michael M. Miller, MD, FASAM, FAPA

Prescription Drug Abuse and Heroin: Impact on Oregon s Youth and Young Adults

Unveiling a new strategy to stop substance abuse in our communities. November 20, 2008 Ingersoll, Ontario

Methadone Maintenance 101

PRESS NOTES YORK INSTRUMENTS Last updated 2018

BRAIN MISSION Understand - fix - enhance

HARM REDUCTION & TREATMENT. Devin Reaves MSW

WHAT IS HARM REDUCTION?

National Strategies for Local Solutions

Care in the Face of the Opioid Epidemic: How Yale University and Yale New Haven Hospital are Reaching Underserved Communities

New London CARES Coordinated Access, Resources, Engagement and Support

Six Years of Opioid-Involved Accidental and Undetermined Fatalities among Connecticut Residents,

Rising Threats in the Nation s Drug Epidemic

Opioid Addiction Statistics

Public Health Association of British Columbia

INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D

Brockton Area Opioid Abuse Prevention Collaborative. Quick Guide

Tri-County Region Opioid Trends Clackamas, Multnomah, and Washington, Oregon. Executive Summary

Pragmatic and Creative Responses to the Opioid Crisis in Connecticut

Strategies for Federal Agencies

Efforts to Address the Opioid Epidemic in Clark County

Data Driven Strategies

Vietnam: The Gift of Recovery, 2013 Sharing our experience, strength and hope for recovery By David J. Powell, Ph.D. Allen Berger, Ph.D.

Care not Corrections SUMMARY REPORT APRIL Relieving the Opioid Crisis in Canada CANADIAN MENTAL HEALTH ASSOCIATION

Rural Prevention and Treatment of Substance Abuse Toolkit

FIGHTING ADDICTION AND IMPROVING BEHAVIORAL HEALTH

Facing Addiction: Key Terms Use Any use of any substance. Driven by market forces. Misuse Use that can harm self or others. Driven by consequences.

The Challenge of Treating Pain

Client s Name: Street City State Zip. Home Phone Work Phone Cell Phone. Student: Full-time Part-time Grade School. Current or past Education:

SUBSTANCE USE DISORDERS

Greenbrier County. West Virginia Board of Pharmacy Prescription Opioid Problematic Prescribing Indicators County Report

Opioid Guardianship Project: Combating the Opioid Crisis Sarah Derr, PharmD Meg Nugent, MHA, RN Iowa Healthcare Collaborative

Aligning Pain Management Community Public Health Presentation

Family Support PACE & HOPE 2014 Annual Report

Economic Costs of Substance Abuse Dheeraj Raina, MD

Removing the Stigma from Substance Use Disorder. Joan Duwve, MD, MPH Associate Dean for Practice Richard M. Fairbanks School of Public Health

Harm Reduction Approaches:

22 April 2002 Central Australian Aboriginal Congress Submission: Taskforce on Illicit Drugs

Neurobiology of Addiction JeanAnne Johnson Talbert, DHA, APRN BC, FNP, CARN AP

Drug Testing Index. A comprehensive analysis of workplace drug use trends

When Trauma Includes a TBI

American Academy of Pain Medicine American Pain Society American Society of Anesthesiologists

History Of Medical Cannabis

Combating Opiate Addiction

What s Up With Opiates?

Delaware Emergency Department Opioid Prescribing Guidelines

Chronic Effects of Neurotrauma Consortium (CENC)

Safe, Healthy, Happy Children

DHCS Tribal MAT Project

Opioid Misuse and Overdose Prevention and Safety. Dr. Kathleen Clanon Medical Director May 31, 2018

FDA s Response to the Opioid Crisis and the FDA Safe Use Initiative

1/26/2016. These are my own thoughts! Safe Workplace Safe Workforce Proven benefits of Stay At Work / Return To Work Process (SAW/RTW)

Drugs. January 30, , 2008 Pearson Education, Inc. Upper Saddle River, NJ 07458

Rethinking trauma as a global

Trauma and Addiction. Building Resiliency in Children And Communities

Barbour County. West Virginia Board of Pharmacy Prescription Opioid Problematic Prescribing Indicators County Report Barbour County

Everyone deserves a suitable, affordable home!

Module 6: Substance Use

INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D

Brockton Area Prevention Collaborative 30 Meadowbrook Road Brockton, MA

Implementing Pain and Opioid Management Guidelines in Primary Care Practice

Concepts to Action: Addressing a Public Health Epidemic. Adam Seidner MD MPH CIC

Brief History of Methadone Maintenance Treatment

Course Lists for Each Day Your courses are the center of your Summer School program experience!

BROMLEY JOINT STRATEGIC NEEDS ASSESSMENT Substance misuse is the harmful use of substances (such as drugs and alcohol) for non-medical purposes.

Statement of the Executive Director UNODC on International Day against Drug Abuse and Illicit Trafficking

Foster Dennin Page 1 AP Lang 3/1/17 Research Paper Recreational Marijuana: Yes or No?

SAMHSA State/Tribal/Adolescents at Risk Suicide Prevention Grantee Technical Assistance Meeting

YOUTH OPIOID ABUSE PREVENTION TOOLKIT

EDUCATIONAL COMMENTARY METHADONE

State of Connecticut Department of Mental Health and Addiction Services. State Innovations in Prevention and Treatment of Opioid Use Disorders

Mingo County. West Virginia Board of Pharmacy Prescription Opioid Problematic Prescribing Indicators County Report

Addressing Substance Use Disorder and the Opioid Epidemic in North Carolina

Putnam County. West Virginia Board of Pharmacy Prescription Opioid Problematic Prescribing Indicators County Report

Pennsylvania Prescription Drug Monitoring Program Trends,

ADDRESSING THE OPIOID EPIDEMIC. Joint principles of the following organizations representing front-line physicians

CONFRONTING THE OPIOID EPIDEMIC. e-book: Introducing OptumRx Opioid Risk Management

batyr: Preventative education in mental illnesses among university students

Drug-Related Deaths in Ventura County

Police Role in the Community. Chapter 11 James J. Drylie, Ph.D.

JSNA Substance Misuse

This event is jointly sponsored by the HealthInsight New Mexico and NMPHA & NM CARES Health Disparities Center.

The Unseen Consequences of Prescription Drug Abuse. Stephen Loyd, M.D.

Alcohol and Drug Abuse Awareness

Responding to B.C. s Illegal Drug Overdose Epidemic

Pocahontas County. West Virginia Board of Pharmacy Prescription Opioid Problematic Prescribing Indicators County Report

Kanawha County. West Virginia Board of Pharmacy Prescription Opioid Problematic Prescribing Indicators County Report

Harm reduction strategies: Reducing the adverse health consequences of drug abuse

Opioid Use and Misuse: History, Trends, And The Oregon Opioid Initiative

Top 10 narcotic pain pills

Methadone Diversion: Why it happens, what the illicit market looks like and the implications

Transcription:

Shan Shan Wu, DO American Osteopathic College of Allergy and Immunology Atopic Dermatitis: new and old treatment updates Atopic dermatitis is a common malady of the young, although it may also affect adults. Control of its triggers such as itch, food, irritants, dryness, infection and etc. may minimize the symptoms (Geoghegan,2017). Defects of skin structures predispose the patients to Typical treatments that have been used for years are well known by parents, grandparents, and practitioners (Powell, 2018). Although helpful in mild types, the more severe have been problematic. Newer biologicals have been exceedingly helpful in the treatment and relief of bothersome symptoms (Davis, 2018). This discussion will review all aspects of old and new therapies in the treatment of 1. Be able to analyze complicated histories involving the background of 2. Understand the cellular reactions that produce 3. Be able to apply diagnostic tests used to determine the causative agents involved in Neha Sanan, DO American Osteopathic College of Allergy and Immunology Theme: Atopic and Contact Skin Disease Urticaria and angioedema are a group of skin conditions that may occur together or individually (Maxim, 2018). Their causation may be the same or dramatically different. Treatment can vastly be different depending on the etiology of the disorder (Dressler, 2018). The more acute events may have a trigger. The more chronic events may have an idiopathic dilemma. Despite the nature of the process, the differential diagnosis is often muddied by physicians, therefore making the effective treatment of the patient delayed. With the appropriate historical ques, appropriate treatment may be initiated. We will discuss the appropriate question algorithm, followed by treatment. Biological therapy will be discussed within each diagnosis (Saco, 2018). Hands-On Demostration 1. Be able to analyze complicated histories involving the background of urticaria and angioedema. 2. Understand the cellular reactions that produce urticaria and angioedema 3. Will be able to apply diagnostic tests used to determine the etiology of urticaria and angioedema.

David Baron, MSEd, DO American College of Osteopathic Neurologists and Psychiatrists Monday, October 8, 2018 1:30-2:30 p.m. Advanced Neuroimaging in Concussion Translational Collaboration Sports concussion occur in over 3.8 million youth every year. Concussions occur in many youths not involved in organized sports programs. Physically abused, bullied, and youths with other neuropsychiatric disorders are at increased risk to sustain concussions that never get reported or clinically evaluated. Mild, repetitive concussions can affect cognitive, emotional and behavioral functioning acutely and after the initial injury. To date, there are no definitive diagnostic assessment tools or reliable biomarkers. Clinicians need to be knowledgeable of current diagnostic criteria and management tools to better evaluate and treat these patients. Advanced neuroimaging holds promise but needs to be carefully evaluated as a clinical tool. The work, of Dr. David Baron, MSEd, D.O.,D.FACN as Chair of the ENIGMA Sports Concussion Neuroimaging Group (the largest in the World) is focused on exploring the value of merging imaging techniques to improve clinical assessment and management of concussed patients, along with an improved understand of the core etiology of immediate and long-term symptoms. This offers significant translational opportunities. Concussion has become the most discussed injury in sports and other at-risk populations (military, homeless, intimate partner violence, substance abusers). 1. Compare and contrast TBI from Concussion. 2. Discuss the role of biomarkers, especially advanced neuroimaging, in concussion assessment and clinical management. 3. List the needs and challenges for future research in concussion neuroimaging. Much of the extant literature on concussion is abstracted from existing concussion and traumatic brain injury papers, or study populations that were taken from an emergency room setting. Concussion and traumatic brain injury are not "identical twins," at best "cousins," with very different initial presentation, clinical phenotype, management strategy, and long-term outcomes. Concussion does not have a signature lesion and often goes undiagnosed and untreated after initial brain insult. This is complicated by the false negative results of virtually all current neuroimaging, including computerized tomography (CT) and positronemission tomography (PET). Advanced magnetic resonance imaging (MRI) and magnetic resonance spectroscopy (MRS); particularly Diffusion Tensor Imaging (DTI) using MRI technology to analyze the movement of water molecules in the white matter of the brain, Diffusion-weighted imaging (DWI), Near-infrared spectroscopy (NIRS),which is a non-invasive means of measuring brain activity using blood flow and oxygen metabolism to infer brain activity and MRS are demonstrating significant promise in providing sensitive diagnostic assessment, and return to play/work/school management of these patients. Clinicians need to be knowledgeable of current diagnostic criteria and management tools to better evaluate and treat these patients.

Amanda Reiman. PhD, MSW Flow Kana, Redwood Valley, CA Sunday, October 7, 2018 Special Note: Speaker for Public Health Program Controlling drugs or people? The history of drug policy in America Drugs were not always illegal in America. There was a time when a person could obtain a prescription for cocaine, heroin, and amphetamine from their physician. However, in 1914 all of that changed with The Harrison Act, the first federal drug law that made it illegal for physicians to prescribe drugs simply due to their patient's dependence on it. Overnight an illicit drug market and associated culture was born. And, after that, the U.S. would engage in "War" on those who did not have the privilege to obtain drugs from private sources. While the media has focused on various "drug epidemics" over the years, this session will focus on the underlying goals associated with these laws and the handling of drug issues in the U.S. 1. Understand the role of race and economic inequality in drug policy creation. 2. Connect the drug epidemics in the U.S. to broader social issues. 3. Reconsider the public health realities of drug epidemics and what might have been more suitable responses. Addressing the opioid epidemic with cannabis Accidental overdose of opiates is now the leading cause of accidental death in the U.S. In America, we comprise 25% of the world's population and consume 99% of the world's hydrocodone. As far back as 1889, doctors have been exploring the use of cannabis for opiate dependence. A sharp increase in opiate fatalities coupled with the population most impacted has regulators, researchers and others looking for novel approaches, including cannabis. This session will focus on three points at which cannabis can interface with opiates to encourage harm reduction: as a first line defense for pain, as a withdrawal medication, and as a maintenance medication to prevent relapse. Research in the area of cannabis and harm reduction will be presented. 1. Understand the current state of opiate use and abuse in the United States. 2. Explore the use of cannabis as a substitute for opiates in various settings. 3. Question the preference for opiates over cannabis in pain management and the stigma against cannabis in recovery.

Sheldon Yao, DO American Academy of Osteopathy Saturday, October 6, 2018 3:00 4:00 p.m. Special Note: AOA Funded Project topic of presentation Impact of OMM on Parkinson s Disease: Lessons Learned and Future Directions This presentation will focus the development of our research study which was funded by the AOA in September 2016 to investigate the effects of OMM on Parkinson's Disease motor function and biomarkers. In sharing the challenges and accomplishments from the study we hope that the audience will gain an appreciation of osteopathic research and learn how they can participate and learn from the challenges we faced. The presentation will focus on Parkinson's disease and how OMM can potentially help our subjects with movement. We will share the results of our studies examining the potential mechanism of OMM and integrating translation research. Finally we will have a hands on session where participants will learn to apply our PARK-OMM protocol used in the study. Hands on demonstration will be able to: 1. Differentiate the different types of scholarly activity available in osteopathic research. 2. Compare and contrast the differences between traditional double blinded studies versus OMM research involving handson procedures. 3. Formulate and design potential osteopathic research studies. 4. Distinguish the different symptoms of Parkinson's disease. 5. Apply osteopathic principles and our OMM protocol in the treatment of Parkinson's disease symptoms. 6. Discuss potential research tools to conduct clinical and translation research in various medical presentations.

Melissa G. Pearce, DO American Academy of Osteopathy Saturday, October 6, 2018 2:15 3:00 p.m. Special Note: AOA Funded Project is part of the discussion Addressing Health Disparities at a Student-Run Free Clinic and Research Opportunities Several schools and colleges of osteopathic medicine have established student run free clinics, which provide health care for a variety of populations. Some of these clinics serve the institution s community of employees and students, but some also aim to serve the local community, especially those who are underserved. This session explores one such clinic at Touro University California, including research efforts such as assessing whether the clinic is serving its target population, organizing outcomes analysis of new programs, and implementation of the RIOT (Reducing Inflammation with Osteopathic Treatment) study in this venue. will be able to: 1. Utilize the model provided by the Touro University California Student-Run Free Clinic (TUC SFRC) to explore interprofessional education opportunities and service to the local community. 2. Analyze the effectiveness of the TUC Student-Run Free Clinic in meeting goals of the mission statement by understanding target and actual patient populations and seeking ways to further serve those in need. 3. Gain awareness of a means of reducing health disparities utilizing a structural competency model (the HOPE program) within the local community with assessment of inhibiting social factors, organization and utilization of local resources, and outcomes analysis. 4. Analyze the structure of the research study RIOT Reducing Inflammation with Osteopathic Treatment and learn how this research project is incorporated into clinical and community settings.